huntingtin-lowering
-
Roche announces details of its 'pivotal' huntingtin-lowering study
The GENERATION-HD1 trial will test whether RG6042 – formerly Ionis-HTTRx – slows the progression of Huntington's disease
Huntington’s disease research news.
In plain language. Written by scientists.
For the global HD community.
